Elizabeth Plimack
MD, MS
Professor and Chief, Genitourinary Medical Oncology
👥Biography 个人简介
Elizabeth Plimack contributed to the KEYNOTE-564 trial establishing pembrolizumab as adjuvant therapy for high-risk RCC after nephrectomy. Her research also spans urothelial cancer and she has been a principal investigator on key trials in both tumor types. She has contributed to understanding which RCC patients benefit most from adjuvant IO and has led multi-institutional GU oncology trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Elizabeth Plimack 的研究动态
Follow Elizabeth Plimack's research updates
留下邮箱，当我们发布与 Elizabeth Plimack（Fox Chase Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment